Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu in Flu Care

Originally published on Sanofi.com

Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu for the prevention and treatment of influenza or flu in the US. Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing, scientific engagement and distribution of Tamiflu OTC in the US. Tamiflu is currently sold in the US by Genentech, a member of the Roche Group, for prescription use.

“This is a strategic and important transaction for us as we strive to continually bring innovations to the market,” says Alan Main, Executive Vice President, Consumer Healthcare, Sanofi.

“The US market is the largest OTC market in the world and a successful switch of Tamiflu to OTC would support our global cough and cold strategy by expanding into flu with a sustainable point of difference in the market. Tamiflu will offer a significant public health benefit once switched by providing increased access to a safe and efficacious treatment for the prevention and treatment of flu. People would be able to either reduce their chances of getting the flu or, at the first signals, appropriately treat as early as possible during the crucial first 48 hours without having to wait for a doctor’s appointment.”

Flu is a condition for which there is no effective OTC anti-viral treatment. Currently, consumers are only able to treat flu symptoms with available OTC products. Early treatment will help prevent the unnecessary spread of the disease. According to the Centers for Disease Control and Prevention (CDC), over 31 million people in the US suffer from the flu in the US each year, but only about 7 million were treated with an effective product like Tamiflu in 2017.

Under the agreement, in addition to leading the FDA negotiations, Sanofi will be responsible for leading the clinical program and funding all studies needed to support the OTC switch in the US in consultation with leading experts in the field. Roche will continue to market Tamiflu in the rest of the world. Sanofi will retain the rights to first negotiations for switch rights in other selected markets.

Latest News

5 Biggest News Stories of the Week: July 1

As the saying goes, the news never stops — but there’s a lot of it out there, and all of it doesn’t always pertain to our readers. In this weekly news roundup, we’ll cover the top news stories that matter most to our diversity focused audience. 1. A Recap of…

Essence Festival Kicks Off Weekend of Celebrating Black Joy and Culture

Essence Magazine’s annual celebration of Black women and culture got underway with a press conference at the Ashes Powerhouse Theater in New Orleans on Thursday. Essence Festival, known as the “party with a purpose,” was started in 1995 as a one-off event to celebrate Essence Magazine’s 25th anniversary. Over the…

Champions of Pride Part Four: Trailblazers

Pride Month is a time to reflect on the trailblazers, freedom fighters, and history makers who fought valiantly to increase inclusion and representation for the LGBTQ+ community, and who have paved a way for a better tomorrow for future generations. In the last installment of our four-part series celebrating Champions…

PwC on Marching for LGBTQ+ Inclusion

Originally published at pwc.com. PwC is a Hall of Fame company.   Setting the scene In recent years, societies worldwide have seen a growing culture of respect and inclusion for lesbian, gay, bisexual, transgender and queer (LGBTQ+) people — a positive development supported in some cases by improved legal rights….

Mastercard Advances ESG Commitments, Outlining Progress in Annual Sustainability and DEI Reports

Originally published at mastercard.com. Mastercard ranked No. 2 on The DiversityInc Top 50 Companies for Diversity list in 2022.   Mastercard released its 2021 Corporate Sustainability and Diversity, Equity and Inclusion (DEI) reports, highlighting the company’s impact across Environmental, Social and Governance (ESG) to build a sustainable and inclusive digital…